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Decrease in VEGF Expression Induces Intussusceptive
Vascular Pruning
Ruslan Hlushchuk, Martin Ehrbar, Philipp Reichmuth, Niklas Heinimann, Beata Styp-Rekowska,
Robert Escher, Oliver Baum, Philipp Lienemann, Andrew Makanya, Eli Keshet, Valentin Djonov
Objective—The concept of vascular pruning, the “cuting-off” of vessels, is gaining importance due to expansion of
angio-modulating therapies. The proangiogenic effects of vascular endothelial growth factor (VEGF) are broadly
described, but the mechanisms of structural alterations by its downregulation are not known.
Methods and Results—VEGF165-releasing hydrogels were applied onto the chick chorioallantoic membrane on embryonic
day 10. The hydrogels, designed to completely degrade within 2 days, caused high-level VEGF presentation followed
by abrupt VEGF withdrawal. Application of VEGF resulted in a pronounced angiogenic response within 24 hours. The
drastic decrease in level of exogenous VEGF-A within 48 hours was corroborated by enzyme-linked immunosorbent
assay. Following this VEGF withdrawal we observed vasculature adaptation by means of intussusception, including
intussusceptive vascular pruning. As revealed on vascular casts and serial semithin sections, intussusceptive vascular
pruning occurred by emergence of multiple eccentric pillars at bifurcations. Time-lapse in vivo microscopy has
confirmed the de novo occurrence of transluminal pillars and their capability to induce pruning. Quantitative evaluation
corroborated an extensive activation of intussusception associated with VEGF withdrawal.
Conclusion—Diminution of VEGF level induces vascular tree regression by intussusceptive vascular pruning. This
observation may allude to the mechanism underlying the “normalization” of tumor vasculature if treated with
antiangiogenic drugs. The mechanism described here gives new insights into the understanding of the processes of
vasculature regression and hence provides new and potentially viable targets for antiangiogenic and/or angio-modulating
therapies during various pathological processes. (Arterioscler Thromb Vasc Biol. 2011;31:2836-2844.)
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The inaugural capillary plexus of any vascular networkundergoes substantial remodeling for the vasculature to
meet the needs of the developing organ and to establish the
organ-specific angio-architecture.1,2 Vascular pruning is an
essential adaptive mechanism resulting in regression of ex-
cessive vascular branches and creation of hierarchical, ther-
modynamically efficient angioarchitecture. This process has
been known for many decades; in 1873 Roguet nicely
illustrated this important phenomenon and named it “retrac-
tion of capillaries.”3 In 1961 Ashton stated that retraction of
capillaries plays a key role in the reorganization of the
primitive immature capillary network.4 It was considered that
some channels become redundant, blood flow within them
ceases, the lumen obliterates, and the endothelial cytoplasm
and nuclei retract into the parent capillaries leaving behind a
trail of cytoplasm that disappears.5 This was the first pro-
found description of a mechanism of vascular pruning at
capillary level.
In the recent past, the understanding of vascular remodel-
ing has been substantially improved, partially, through de-
tailed investigations and descriptions of the process of intus-
susceptive angiogenesis, and in particular, intussusceptive
vascular pruning (IVP).1,6,7 Our previous morphological stud-
ies have revealed the vasculature of different organs to
undergo 2 main phases of development: an early sprouting
phase followed by an intussusceptive phase, during which
capillary sprouting is superseded by transcapillary pillar
formation. Intussusception results in rapid expansion of the
capillary network and the genesis of an organ-specific vas-
cular tree, as well as its dynamic adaptation and intussuscep-
tive branching remodeling (see review1). An important facet
of intussusception is the IVP. It can be summarized as the
formation of multiple eccentric pillars at the bifurcation
points and their subsequent successive fusions, which leads to
partial and later to total luminal obstruction and separation
(cutting-off) of one of the affected daughter branches. The
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latter mechanism is alternative to the one described by
Ashton and, in contrast, it is not limited to the capillary level
but also involves larger vessels. Vascular pruning results in
reduction of the number of vascular branches and vascular
density respectively. This is one of the mechanisms allowing
the vascular system to dynamically adapt to the changing
hemodynamical and metabolic influences and to create ma-
ture hierarchical and even more efficient angioarchitecture.8
The remodeling process is regulated by mechanical influ-
ences (hemodynamics), as well as by numerous not yet
well-defined morphogens and cytokines. The most potent and
best known angiogenic factor, vascular endothelial growth
factor (VEGF)-A, plays a major regulatory role in the
formation of blood vessels and is known to control prolifer-
ation and migration of endothelial cells.8–10 Proliferation of
endothelial cells is regulated by absolute concentration of
VEGF, whereas their migration and differentiation toward
different functionalities depends on the concentration gradi-
ent of different VEGF-isoforms.11,12 VEGF also influences
the survival of vascular endothelial cells.9 Our ongoing
studies in the developing kidney revealed the relation be-
tween VEGF downregulation and intussusceptive pruning (A.
Makanya et al, unpublished data). The sustained VEGF
expression or, respectively, its inhibition was shown to play
an important role in vascular remodeling.13,14 The finding by
Keshet’s group that VEGF is the molecular link between
hypoxia and angiogenesis was a milestone in the field of
hypoxia-driven angiogenesis.15 In a previous study we dem-
onstrated that inhibition of VEGF/VEGF-R signaling path-
way led to vessel degeneration in the chick chorioallantoic
membrane (CAM), most probably by means of vascular
pruning.16 Moreover, in a recent study we described how
application of a VEGF inhibitor in the mouse xenografts
tumor model led to a temporary switch in the angiogenesis
mode: from sprouting to intussusception.14 The described
findings underpin the paramount role of VEGF (or actually its
inhibition) in activation of intussusceptive angiogenesis, and,
in particular, IVP.
In the present study we have investigated one of the
possible regulatory mechanisms underlying intussusceptive
angiogenesis, the one involving VEGF-signaling pathways.
We show here that IVP is preceded by a reduction of
available VEGF. We have described the morphogenesis of
IVP and discussed the biological and clinical relevance of this
fundamental vascular process.
Materials and Methods
Local Application of VEGF-A
A 1.0 g recombinant VEGF-A165 protein (Peprotech, London) was
administered in a 10 L 2% (weight /Volume) synthetic fibrin
analog hydrogel. The hydrogels were formed under physiological
conditions by enzymatic cross-linking of 8-arm star-shaped poly
(ethylene glycol) PEG polymers, which are functionalized with
substrate sequences for FXIIIa as previously described.17 Hydrogels
without addition of VEGF-A165 were used as vehicle controls. In
order to facilitate the localization of the applied hydrogel and
estimate the level of its degradation on the CAM in some experi-
ments FITC-labeled peptides Lys-FITC (Ac-FKGGK-fluorescein-
NH2, NeoMPS, Strasbourg, France), which are covalently tethered to
the forming hydrogels, were added.
Intravital Microscopy of CAM Vasculature
Chorioallantoic membranes were obtained by incubating chick
embryos using the established shell-free culture method.18 On E10
portions of the CAM surface were treated with hydrogels that either
contained or did not contain 1 g of VEGF-A165. Twenty four, 48,
and 72 hours after the application, the CAMs were intravenously
injected with up to 0.1 mL of 3% FITC-dextran solution [molecular
weight: 2000000 Da (Sigma, Buchs, Switzerland)], prior to inspec-
tion in an epifluorescence microscope (Polyvar-Reichert, Glattbrugg,
Switzerland) equipped with a Canon 5D Mark II camera for both
video recording and taking of still images. The still images and video
sequences of at least 4 fields of view were taken per application site
for further quantitative evaluation. The total number of branching
points per field of view was assessed using analySIS Software 5.0
(Soft Imaging System, Muenster, Germany) by means of user-driven
skeletonization of the vasculature.
The Multiple Image Alignment tool of the aforementioned soft-
ware was used to obtain overview images representing the whole
application site with degrading gel at different timepoints. In cases
where the applied gels contained FITC labeled peptides, we injected
up to 0.1 mL of 3% Rhodamine B isothiocyanate dextran solution
[molecular weight: 70000 Da (Sigma, Buchs, Switzerland)] in
isotonic NaCl solution.
Determination of Remaining VEGF by
Enzyme-Linked Immunosorbent Assay
We harvested and homogenized 1 cm2 sized CAM samples from the
site of treatment (including remaining hydrogel mass) in 500 L
lysis buffer (PBS pH 7.2, 0.1% Tween, 0.2% BSA, 1 mmol/L
Benzamidine, 20 mmol/L NaF, 1 mmol/L PMSF, 2% Protease
Inhibitor Cocktail Set III [Calbiochem, Darmstadt, Germany]) and
incubated for 24 hours at 4°C on a rotating wheel. VEGF-A165
content in the lysis buffer was assessed using a human VEGF
enzyme-linked immunosorbent assay (ELISA; PeproTech, London,
UK) according to the manufacturer’s protocol.
Semithin Serial Sectioning
CAM samples of sites of interest were harvested and fixed in 2.5%
(v/v) glutaraldehyde solution buffered with 0.03 mol/L potassium
phosphate (pH 7.4, 370 mOsm). They were then postfixed in 1%
OsO4 [buffered with 0.1 mol/L sodium cacodylate (pH 7.4, 340
mOsm)], dehydrated in ethanol, and embedded in epoxy resin.
Thousands of 0.8-m–thick serial sections were prepared using glass
knives and stained with Toluidine Blue. The serial sections were
viewed and images captured at low magnification using a light
microscope (Leica, Leitz DM), equipped with Leica DFC480 cam-
era. The set of images obtained was aligned using Adobe Photoshop
CS3 Software and imported as stacks into Imaris Software for low
resolution 3D-reconstruction. The ensuing 3D data enabled exact
localization of the branching points of interest based on direct
comparison with the in vivo microscopy images of corresponding
sites. Then images of the defined sections were taken at high
magnification (1000) and the site of interest was reconstructed at
high resolution by using the procedure described above.
Vascular Casting
Vascular casts were prepared as previously described.19 Briefly,
CAM vasculature was perfused with a freshly prepared solution of
Mercox (Vilene Company, Japan) containing 0.1 mL of accelerator
per 5 mL of resin. One hour after perfusion, the CAM were
transferred to 7.5% potassium hydroxide for dissolution of tissue,
which was effected over a course of 2 to 3 weeks. After washing, the
casts were dehydrated in ethanol and dried in a vacuum desiccator.
The samples were then sputtered with gold to a thickness of 10
nm and examined in a Philips XL-30 SFEG scanning electron
microscope.
Index of Intussusception and Statistical Analysis
From video sequences the number of branching points involved in
intussusception (ie, those showing pillars) could be assessed. The
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vasculature skeletons on the corresponding still images were used
to find out the total number of branching points per each
investigated field of view. By dividing the number of intussus-
ception involved branching points by the number of branching
points, the index of intussusception could be determined. At least
4 fields of vision per application site were evaluated (n4 per
time point and per group, at least 16 fields of vision per time point
and group) The used magnification was 40. Statistical analysis
was done using the 2-tailed t test. The difference was considered
significant if P0.05.
Apoptosis Assay
Apoptotic cells were detected in vivo using Annexin V-FITC
apoptosis detection kit (Sigma-Aldrich Chemie GmbH, Stein-
heim, Germany). The solution was injected directly into the CAM
vascular system. After 15 minutes of incubation the vasculature
was examined using a Leica AF 6000LX fluorescence microscope
equipped with the Leica DFC 360FX digital camera. Annexin
V-positive (apoptotic) cells appeared as green spots in the
images obtained.
Results
VEGF Release Profile
An angiogenic response was stimulated by local application of
gels loaded with 1 g of VEGF or empty gels (control) on top
of growing chick CAM at E10. To allow the estimation the
VEGF release profile we have added Lys-FITC to the gel
composition. The FITC labeling of the hydrogel enabled the
visual presentation of the proteolytic gel degradation and
allowed the correlation of proteolysis-triggered release of
VEGF with the amount of the remaining hydrogel mass20
(Figure 1). Another advantage of this application method is
that removal of the gel after certain application time was not
necessary in our experiments, avoiding the very often ob-
served nonspecific reactions of the CAM vasculature due to
mechanical damage or irritation.21 The gel was considerably
degraded as early as 24 hours and completely degraded in 48
Figure 1. Hydrogel based delivery of vascular endothelial growth factor (VEGF). An overview of gel (asterisk) just after its application on
an E10 CAM is presented in A. In the background the vascular network was visualized by intravenous injection of RITC-dextran. At 24
hours after the application (B) the amount of gel was remarkably reduced. At 48 hours (C) only traces of the gel (arrows) could be
detected. The graph showing the normalized VEGF levels obtained by ELISA is presented in D (mean values SD; n3). Contr indi-
cates control.
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hours after the application (Figure 1A–1C) and no more
detectable at later time-points (data now shown).
Determination of the VEGF-A levels using ELISA-kit has
corroborated that the amount of exogenous VEGF-A re-
mained at a significantly higher level at 24 hours when
compared to controls. At 48 hours VEGF expression de-
creased back to the level in control samples (Figure 1D).
Thus, in our model an exhaustive stimulation by exogenous
VEGF was achieved for more than 24 hours followed by a
drastic drop in VEGF levels by 48 hours.
Morphogenesis of IVP
In order to investigate the detailed morphology of the affected
vasculature we made vascular corrosion casts of CAMs at 24
and 48 hours after VEGF application. Observation of casts
using scanning electron microscope corroborated the hypoth-
esis that besides the differences between control (Figure 2a)
and VEGF-treated samples, there was a qualitative change
between the vasculature during VEGF stimulation (at 24
hours) (Figure 2B) and when the VEGF presentation was
discontinued, namely at 48 hours (Figure 2C–2H). In the
latter ones there were numerous bifurcations involved in IVP.
Various stages of the pruning process were documented on
vascular casts made at 48 hours after VEGF-A application
(Figure 2C–2H). Initially single eccentrically positioned pil-
lars (arrowheads in Figure 2) arise (Figure 2C–2D), they then
grow in number and girth (Figure 2D), and folds (arrows in
Figure 2) emerge between them (Figure 2E–2F). As the folds
become deeper (Figure 2F–2G), pillars fuse and finally lead
to the “cutting-off” of the corresponding vessel branches
(Figure 2G). These changes take place simultaneously in a
“cascade-like” manner at many branching levels, from cap-
illary plexuses up to larger vessels (Figure 2H). Note the
IVP-altered capillary plexus indicated with an asterisk in
Figure 2H.
Apparently, IVP was activated 48 hours after VEGF-A
application, soon after the dramatic decrease in VEGF-A
expression.
Time Course of IVP
Time-lapse in vivo video microscopy (Figure 3) confirmed
the aforementioned activation of IVP following VEGF-A
downregulation by revealing the appearance of many asym-
metrically positioned pillars, the hallmarks of intussusceptive
pruning. The fast appearance and progression of the pillars
(within hours) enabled the documentation of various stages of
IVP in vivo: from appearance of single eccentrically posi-
tioned pillars to formation of pillar rows (Figure 3A–3C) and
almost complete “cutting-off” of the daughter vessel with
drastic decrease in the size of its orifice resulting in the vessel
being hardly patent. The same fate befell the neighboring
capillary plexus (Figure 3D–3F). The corresponding vascular
cast image with multiple intussusception involved branching
and, due to pruning altered capillary plexus, is presented in
Figure 2H.
These findings illustrate the rapid change in vascular
structure accomplished by intussusception.
High Resolution 3D-Reconstruction Using Serial
Semithin Sectioning
The branching point of interest with emerging pillars ob-
served in vivo (Figure 4A–4C) was fixed just after the last in
vivo observation and then processed for semithin sectioning.
Over 2000 serial 0.8 m-thick sections were made with the
cutting plane being perpendicular to the CAM surface and
stained with toluidine blue. Low magnification images of
these sections were acquired, aligned, and processed for low
resolution 3D-reconstruction using Imaris Software. The data
obtained by 3D-reconstruction was used for precise localiza-
tion of the vascular segment of interest (white rectangle in
Figure 4C) by superimposing it with the in vivo images.
Afterward high magnification images of determined sites in
140 sections were acquired for high resolution 3D-
Figure 2. Intussusceptive vascular pruning revealed by vascular
casting technique. Control CAMs showing a regular vascular
network with an intact capillary plexus between artery (A) and
vein (V) (A). The vascular casts made at 24 hours post-
application displayed the angiogenic stimulation (B) with a
dense tree of enlarged feeding vessels and numerous side
branches. At 48 hours after application there was a remarkable
activation of intussusception at the branching points (C–H).
Unlike the controls, in the VEGF-treated sites asymmetrically
positioned pillars (arrowheads in [C–H]) or connecting folds
(arrows in E–H) were frequent findings. Various stages of the
pruning process were found: where pillars grow in girth and
number (C and D), fuse by growing folds (arrows) and lead to
subsequent “cutting-off” of the corresponding vessel branches
(E–G). The simultaneous “cascade-like” intussusceptive pruning
at different hierarchical levels of venous tree is presented in H.
The larger vessels as well as the capillary plexus (asterisk) are
altered. The insert in H shows the asymmetrically positioned
pillars (arrowheads) and the folds between them (arrows).
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reconstruction: the virtual section through the 3D-stack is
presented in Figure 4D. Further, the 3D surface of the
vascular lumen of the in vivo segment of interest was
computer generated (Figure 4e) and corresponded to the in
vivo obtained images (see Figure 4C for comparison). The
intraluminal view demonstrates clearly that the structures
observed in vivo were emerging pillars (Figure 4F). On the
corresponding semithin sections, the intraluminal protrusions
of endothelial cells at the opposing sides of the vascular
lumen were apparent (Figure 4G–4H).
Adaptation (Regression) of the Vasculature
Happens at Different Hierarchical Levels, and
Including Larger Supplying Vessels
At 72 hours after VEGF application even the usually rigid
larger arteries also underwent the intensive process of adap-
tation (Figure 5). Intussusceptive pruning and remodeling
was not restricted to distal part of vasculature but could be
observed along the entire vascular tree (Figure 5B–5D). This
presents the integrity of the vasculature system adaptation
and involvement of intussusception in the regressive remod-
eling at all hierarchical levels of the vasculature.
Morphometry of the Affected Vasculature
Quantification of intussusception was done using the data
obtained using in vivo microscopy. The parameter we have
chosen as the measure of intussusception was the index of
intussusception involved branching points. The results obtained
have corroborated the qualitative description: In the control
areas, there were no significant changes of this parameter at all
3 time-points. On contrary, the VEGF-A treated areas were
characterized by a constant increase of intussusception involved
branching points with the most prominent value (2.5fold in
comparison with control) at 72 hours (Figure 6).
Apoptosis of Endothelial Cells at Remodeled Sites
To address the question whether the endothelial cells undergo
apoptosis we made the additional experimentation: The IV
injection of FITC-labeled anti-Annexin–V apoptosis detec-
tion kit was made prior in vivo observation of the VEGF
application sites. The apoptotic cells could be found at 48
hours and more after the application. At E1048 hours there
were scattered apoptotic cells in the capillary plexus and at
E1072 hours one could observe already bigger vessels with
numerous Annexin-V–positive cells (see Figure 7).
Discussion
Mechanism of Vascular Pruning
The mechanism of IVP has been rather explicitly described in
the last decade.6,22 At the initial stage intraluminal protrusions
of endothelial cells lying at the opposing sides of the vessel
are formed. The contact between them has to be established
for the single pillar to emerge. The peculiarity of IVP is that
the pillars are positioned eccentrically from the axis of the
mother vessel. During the progression of IVP the pillars
increase in number and size, they fuse by folds, and finally
lead to complete “cutting-off” of one of the daughter vessels.
Importantly, this process that leads to regression of the
vasculature takes place at all levels of the vascular bed, from
capillary plexus to larger vessels (see Figure 2 and Figure 5).
Figure 3. Time-lapse in vivo microscopy at 24 (A, B), 48 (C–E) and 62 (F) hours after vascular endothelial growth factor (VEGF) gel
application. A–C: The branching of interest (rectangle in A) is presented at higher magnification in B and shows no signs of intussus-
ceptive pruning at 24 hours after VEGF-A application. The pillars (arrowheads in C) emerged within the next 24 hours and were aligned
in a row at the origin of one of the daughter vessels. A more advanced stage of vascular pruning is presented in D–F: The branching of
interest marked in D is presented at higher magnification in E. The branching undergoes intussusceptive pruning at 48 hours after
VEGF-A application: Rather large pillars (arrowheads in E) separate the daughter vessel. After another 14 hours the pillars further
increased in size decreasing the orifice of the daughter vessel (red arrows in E and F) and making it and neighboring capillary plexuses
(asterisks in F) barely patent. Arrows in F point at the disappearing connections to the capillary plexus which correspond to the rows of
folds as displayed in Fig. 2G. F corresponds to image of vascular cast in Fig. 2G and 2C to the one in Fig. 2E.
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VEGF and IVP
VEGF Application Stimulates Angiogenesis in the CAM
In the present study we could observe typical signs of
stimulated angiogenesis following application of VEGF-A. It
is well described that in addition to the amount of the applied
or expressed VEGF, its release modality, ie, slow versus rapid
liberation, is a crucial factor for the angiogenic response and
vascular morphogenesis.23–26 Considering the data in the
literature, the fibrin gel application was chosen to create an
interface between CAM and VEGF-A reservoir and allow a
sustained release during the proteolytic degradation of the
gel. Microscopical and ELISA-based analysis suggest an
exogenous VEGF presentation that lasts for approximately 24
hours after application and that once the gels are completely
degraded rapidly terminates. The reversion to the physiolog-
ical level at 48 hours (on E12) is confirmed by VEGF-ELISA.
VEGF-A Withdrawal Leads to IVP
Although decrease of VEGF concentration has been previ-
ously presumed to induce vascular remodeling and prun-
ing,6,27,28 this hypothesis could only now be affirmed in the
present study both qualitatively and quantitatively. Within a
rather short time after the decrease of VEGF concentration we
observed appearance of many asymmetrically positioned
pillars at branching points. Our observations indicate that
intussusceptive pillar formation is a major mechanism in
VEGF-dependent vascular pruning. This finding is in accor-
dance with other studies describing induction of intussuscep-
tion and degeneration of immature vessels after inhibition of
VEGF-signaling14,16,29 or hyperoxia-induced withdrawal of
VEGF.30,31 In contrast to the mentioned studies we show here
that (VEGF-dependent) IVP is not limited to the immature
vasculature but takes places at higher hierarchical levels of
the mature vascular bed (see branching of the larger arteries
Figure 4. Three dimensional reconstruction of structures observed in vivo. On the overview image (A) the site of interest is marked and
then presented at higher magnification at later time points (B, C). At 62 hours after application (B) one appearing pillar (black arrow-
head) was observed in a supplying vessel, after another 10 hours the second pillar was emerging (white arrowhead in C). The site of
interest (white rectangle in C) was then processed using serial semithin sectioning and the corresponding 3D stack of the images was
obtained. The virtual section through this stack is presented in D (the contour of the vessel segment [Ve] is marked with the dashed
line). The 3D surface of the vascular lumen was generated: E shows the overview of the vascular segment of interest with arrowheads
indicating the structures corresponding to the ones indicated in C. The intraluminal view (F) demonstrates the emerging pillars (double
arrowheads) at closer distance. The lines in D mark the position of the toluidine blue-stained semithin sections that are presented in G
and H, showing the emerging pillars (double arrowheads of corresponding color).
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in Figure 5). We believe that the IVP of larger mature vessels
may be secondary to hemodynamic changes in distal vascular
segments, ie, capillary plexus.
There are controversial data in the literature about the fate
of the occluded vascular segments. Although most authors
postulate that the process involves apoptosis,16,27,30 pruned
ECs may also reassemble into other vessels or dedifferenti-
ate.32,33 In our model the process of vascular pruning defi-
nitely involves apoptosis (Figure 7) but involvement of other
mechanisms cannot be excluded.
Clinical Implications
Inhibition of angiogenesis is a promising strategy for treat-
ment of cancer and other disorders, whereas promoting
growth of new vessels is important for treatment of ischemic
disorders. Most antiangiogenic agents in tumor treatment are
targeting VEGF signal transduction.34,35 The antiangiogenic
treatment was supposed to deprive the supply of oxygen and
nutrients to the tumor by destroying its vasculature. Even a
single infusion of bevacizumab, a VEGF-specific antibody,
was shown to significantly reduce the microvascular density
in rectal carcinoma patients.36 However, the survival benefits
of antiangiogenic drugs have thus far been rather disappoint-
ing, stimulating interest in developing more effective ways to
combine antiangiogenic drugs with established chemothera-
pies.12,37 In the recent past it has been proved that an
antiangiogenic approach, when combined with chemother-
apy, results in increased survival in patients with advanced
malignancies.8,34 The improved efficacy is nowadays often
explained by “vascular normalization.” The hypothesis of
transient “normalization” of the vasculature states that some
antiangiogenic drugs improve tumor perfusion by reducing
Figure 5. Micrographs from in vivo imaging showing the cascade-like intussusceptive remodeling of the arterial tree after VEGF down-
regulation. A low magnification image of an artery (Ar) with several branchings is shown in A. The branchings undergoing intussuscep-
tive remodeling and pruning (white rectangles in A) are displayed at higher magnification in panels B–D. The pillars and meshes evident
on the vessels (arrowheads in B–D) lead to simultaneous IVP and remodeling (dashed lines in B–D) at more proximal and distal branch-
ing points. This shows the integrity of vascular tree adaptation by means of intussusceptive pruning following vascular endothelial
growth factor (VEGF)-A downregulation. The branches separated via IVP are indicated by asterisks in B–D. This figure supports the
data shown in Fig. 2H that remodeling takes place at different hierarchical levels and is not limited to venous compartment.
Figure 6. Quantitative evaluation of intussusceptive pruning at
branching points. The graph represents the index of intussus-
ception at 24, 48, and 72 hours after vascular endothelial
growth factor (VEGF) gel application. The VEGF-A treated areas
were characterized by an outstanding increase (P0.01) of the
intussusception involvement at 72 hours, at the time-point when
VEGF-A expression was already significantly decreased. In the
controls there was no significant change between the time-
points. The values represented in the graph are meanSD
(n4).
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vascular density, stabilizing the vessel wall (perivascular cell
and basement membrane coverage), reducing the interstitial
fluid pressure, and hence increase the penetration of the
chemotherapeutic drug into the tumor.38,39 The underlying
morphological mechanisms have not been clearly elucidated
yet. In this study we demonstrate for the first time that
decrease in VEGF-A concentration leads to intussusceptive
remodeling of the vasculature, including pruning. Combined
with our previous study on tumor recovery after antiangio-
genic treatment this observation may allude to the mechanism
underlying the “normalization” of tumor vasculature: VEGF
inhibition not only stops further angiogenesis but also leads to
transient tumor shrinkage via vascular elimination associated
with vessel normalization by activation of IVP and
remodeling.
In conclusion, the mechanism of VEGF-dependent IVP
described here gives new insights to the understanding of the
process of vasculature regression, which is in line with the
newer findings of nonsprouting angiogenesis and might
provide new potential targets for antiangiogenic therapy.
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